Vedana Therapeutics

News

Our latest roundup of financings in the biotech sector includes solid eight-figure rounds for Triveni, Cellares, HMNC, Vedana, and Neion Bio.

News

Keenova is hoping that its Xiaflex drug can become the first approved therapy for plantar fibromatosis, a debilitating condition affecting the feet.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.